ClinicalTrials.Veeva

Menu

Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG) (IMPACT)

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Completed

Conditions

Coronary Artery Bypass Graft
Anomalies in Glucose Metabolism

Treatments

Other: Collection of clinical data
Other: Collection of biological data

Study type

Observational

Funder types

Other

Identifiers

NCT02855879
VERGES 2014

Details and patient eligibility

About

The aim of this study is to determine the prevalence of diabetes and non-diabetic glucose metabolism anomalies (glucose intolerance, non-diabetic fasting hyperglycaemia in patients about to undergo coronary artery bypass grafting (CABG).

In addition, the effect of these anomalies on post CABG morbi/mortality in the short term will be evaluated.

Enrollment

286 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • persons who have provided oral consent
  • patients about to undergo coronary artery bypass grafting
  • age >18 years

Exclusion criteria

  • persons without national health insurance cover
  • Adults under guardianship
  • Pregnant or breast-feeding women

Trial design

286 participants in 1 patient group

CAD patients
Treatment:
Other: Collection of biological data
Other: Collection of clinical data

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems